Stifel Trust’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q3
$165K Buy
847
+67
+9% +$13.1K 0.03% 191
2014
Q2
$191K Buy
780
+20
+3% +$4.9K 0.04% 182
2014
Q1
$202K Sell
760
-472
-38% -$125K 0.04% 178
2013
Q4
$448K Buy
1,232
+99
+9% +$36K 0.08% 141
2013
Q3
$603K Buy
1,133
+133
+13% +$70.8K 0.12% 131
2013
Q2
$235K Buy
+1,000
New +$235K 0.05% 167